View Future GrowthEden Research 過去の業績過去 基準チェック /06Eden Researchの収益は年間平均-31.4%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間0.4% 11.5%割合で 増加しています。主要情報-31.39%収益成長率-22.25%EPS成長率Chemicals 業界の成長12.93%収益成長率11.46%株主資本利益率-12.03%ネット・マージン-38.70%前回の決算情報30 Jun 2024最近の業績更新お知らせ • Sep 15Eden Research plc to Report First Half, 2025 Results on Sep 17, 2025Eden Research plc announced that they will report first half, 2025 results on Sep 17, 2025お知らせ • Sep 20Eden Research plc to Report First Half, 2024 Results on Sep 23, 2024Eden Research plc announced that they will report first half, 2024 results on Sep 23, 2024お知らせ • May 09+ 1 more updateEden Research plc to Report Fiscal Year 2023 Results on May 07, 2024Eden Research plc announced that they will report fiscal year 2023 results on May 07, 2024お知らせ • Sep 30Eden Research plc to Report First Half, 2023 Results on Sep 29, 2023Eden Research plc announced that they will report first half, 2023 results on Sep 29, 2023お知らせ • May 05Eden Research plc to Report Fiscal Year 2022 Results on May 05, 2023Eden Research plc announced that they will report fiscal year 2022 results on May 05, 2023すべての更新を表示Recent updatesお知らせ • Apr 30Eden Research plc Provides Revenue Guidance for the Fifteen Months Ending 31 March 2026Eden Research plc provided revenue guidance for the fifteen months ending 31 March 2026. For the period, revenue is expected to be c. £4.9 million.お知らせ • Feb 06Eden Research plc has completed a Follow-on Equity Offering in the amount of £0.150419 million.Eden Research plc has completed a Follow-on Equity Offering in the amount of £0.150419 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,760,473 Price\Range: £0.04お知らせ • Feb 02+ 1 more updateEden Research plc has filed a Follow-on Equity Offering in the amount of £0.5 million.Eden Research plc has filed a Follow-on Equity Offering in the amount of £0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 12,500,000 Price\Range: £0.04お知らせ • Jan 07Eden Research plc Announces Mevalone Label Extension in FranceEden Research plc announced that Mevalone has been granted approval by the French authorities for use on grapes to control downy and powdery mildew, subject to customary restrictions. France is one of the world's largest and most affected markets for grape downy mildew, and this is driving steady demand for conventional fungicides, biopesticides, and resistant varieties across its more- than 780,000 hectares of vines. While any estimate is subject to ever-evolving regulatory and commercial circumstances, the Company currently estimates that the potential peak revenue for this opportunity (with its current label extension conditions on the timing of applications) to be in the region of up to EUR8 million per annum. Given the timing of receipt of this label extension for two new diseases and the industry's schedule for marketing and stocking products for the growing season, the Company is not changing its market guidance at this stage but will monitor this as the season develops.お知らせ • Nov 22Eden Research plc Announces 3Logy Receives Approval by the Italian Authorities for Use on Several New CropesEden Research plc announced that 3LOGY (predominantly known as Mevalone®? outside of Italy) has been granted approval by the Italian authorities for use on numerous new crops in order to control Botrytis and a range of new diseases, including powdery mildew and Sclerotinia. The label for 3LOGY has been expanded over time from a specialised fungicide for grey mould (Botrytis cinerea) in grapes to a broad-spectrum fungicide for multiple horticultural crops following its first label extension in Italy in 2022. Now a leading biofungicide in the Italian market, 3LOGY has efficacy on crops that require the highest quality standards, including leafy vegetables, table grapes, and kiwis. The new crops approved for 3LOGY include legumes (such as peas, lentils, and chickpeas) as well as other crops such as avocado, carrot, radish, celery and asparagus. Together, the new label extensions grow the addressable market in Italy by more than twenty thousand hectares and provide 3LOGY with the opportunity to play a key role in the sustainable cultivation of these high-value crops. Beyond the enlarged addressable market in Italy, 3LOGY offers additional value for growers simply due to the extensive list of crops on which it can now be used. This versatility allows farmers to use it as a reference fungicide across cultivated open fields and in greenhouses for certain crops. This label extension reflects Eden's ongoing strategy to grow its core business through the addition of not only new products, but also through the expansion of regulatory authorisations for existing products that have substantial additional potential beyond simple territorial expansions. This label extension enhances Eden's competitive position within the fungicide segment. Sipcam Italia and 3LOGY are now considered top-of-mind products for Italian growers in a market with limited options. Although the potential sales gains are difficult to quantify.お知らせ • Nov 18Eden Research plc Announces Ecovelex 2025 Approval in ItalyEden Research plc announced that Ecovelextm 2025 has been granted temporary approval in Italy (in accordance with Reg. EU/1107/2009) for use as a bird repellent seed treatment on maize for the 2026 growing season. The temporary approval in Italy enables Eden to sell Ecovelex whilst await full EU-wide authorisation, which is expected in due course. Ecovelex represents a new entrant into the seed treatment market and is a replacement for conventional chemicals that are no longer approved in the EU and UK. It was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by emitting an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product, developed by Eden at its Oxfordshire facility, is based on Eden's plant-derived active ingredients, which the Company has registered in the EU, US, Mexico and elsewhere. Ecovelex has also been formulated using Eden's Sustaine®? plastic-free microencapsulation system. It is designed to support farmers as they strive to meet consumer and regulatory demands for more sustainable agriculture. In 2023, Eden submitted the regulatory dossier and application to Austria, which is acting as the interzonal rapporteur member state on behalf of the EU. Authorisation is expected in due course, with each EU member state then required to ratify the authorisation or request additional information before granting local authorisations.お知らせ • Sep 15Eden Research plc to Report First Half, 2025 Results on Sep 17, 2025Eden Research plc announced that they will report first half, 2025 results on Sep 17, 2025お知らせ • May 29Eden Research plc, Annual General Meeting, Jun 18, 2025Eden Research plc, Annual General Meeting, Jun 18, 2025. Location: one bartholomew close, ec1a 7bl, london United Kingdomお知らせ • Dec 20Eden Research plc Receives Regulatory Approval in Mexico for Novellus+ in MexicoEden Research plc announced that it has received regulatory approval in Mexico for Novellus®?+, a new, enhanced version of its fungicide, Mevalone O. The product's regulatory approval applies to its use against botrytis on a range of horticultural crops, comprising grapes, tomatoes, peppers, potatoes, strawberries, blueberries, raspberries, Gooseberries, eggplant, okra, as well as several other high value fruit and vegetables. Novellus+ will be exclusively distributed and sold by Sipcam Oxon's Mexican subsidiary, Advan Mexico SA de CV ("Advan"). This is also an exciting development as Novellus+ represents an evolution of Mevalone, allowing improved rates in the field, high levels of efficacy and a broader list of targets, all contributing to a larger addressable market in select territories. Registration efforts are also well underway in several additional countries, and the company look forward to providing further updates on the growth of Novellus+ within portfolio. The company believe that the sustainability and efficacy of Novellus+ will stand company product apart in a growing market, particularly as local regulations increasingly demand strict control of pesticide residues on fruit and vegetables in order to meet consumer expectations and international standards. This milestone further strengthens the product development pipeline in key markets where Sipcam Oxon operates through its affiliates. With its high-value crops and vegetables, primarily grown for export, Mexico offers significant market potential for botanical products like Novellus+. The successful development of Novellus+ highlights the fruitful collaboration between Eden and Sipcam, combining their expertise to create an enhanced formulation that delivers consistent efficacy and versatility.お知らせ • Dec 13Eden Research plc Announces That Its Fungicide, Mevalone Has Been Registered as an input for Organic Farming in GermanyEden Research plc announced that its fungicide, Mevalone, has been registered as an input for organic farming in Germany. The Input List for organic production in Germany is managed by the Research Institute of Organic Agriculture, FiBL, a European organisation with presence in several countries and with well-recognised and respected activities related to sustainability and organic farming. This inclusion has been granted by experts who evaluate farming inputs for their compliance with the requirements of organic production in Germany and multiple other countries. The news follows the approval of Mevalone in Germany, announced in August 2024. Eden's German commercial partner, Sumi Agro Deutschland, which has a strong focus on supporting organic farmers, has reinforced the importance of having this registration by FiBL Germany to better address the needs of organic growers in Germany. This policy exceeds the 25% of organic farmland in the EU as set in the EU Green Deal and means that significant action is required by the entire agriculture sector to reach this goal. Therefore, the registration of Mevalone as an input fororganic farming in Germany positions the product as a significant contributor to support German farmers to achieve their targets whilst also retaining productivity. With FiBL Germany's addition of Mevalone to the Organic Input list, Eden expects its fungicide to become an even more versatile product used by German organic growers to effectively control fungal diseases and to avoid production loss, whilst also remaining consistent with the requirements of organic agriculture.お知らせ • Oct 08Eden Research Delists from the OTCQB Exchange in the USEden Research plc announced that it has, as of October 8, 2024, delisted from the OTCQB exchange in the US. Following a review of its capital markets strategy, the Board of Eden has taken the decision to delist the Company from the US-based OTCQB exchange in light of the low trading activity of the Company's ordinary shares on that exchange. The delisting will have no impact on the Company's ordinary shares, which will continue to trade on AIM.お知らせ • Sep 20Eden Research plc to Report First Half, 2024 Results on Sep 23, 2024Eden Research plc announced that they will report first half, 2024 results on Sep 23, 2024お知らせ • Sep 02Eden Research plc Announces Temporary Approval for Cedroz in GreeceEden Research plc announced that Cedroz has been granted, according to Reg. EU/1107/2009, a temporary approval in Greece for use on potatoes against wireworms for the 2024 growing season. Cedroz, whose distributor in Greece is Eastman Chemical; Eden's commercial partner in a number of countries, will now be permitted for use on potatoes against wireworms. Wireworms are the larvae of click beetles which cause damage to potatoes by forming a mass of holes and mini-tunnels on the vegetables. This pest is becoming increasingly problematic in many crops and regions, and farmers have very few options (most of them based on synthetic insecticides) to minimise its negative impact on the harvest. The Wireworm-infected area of potatoes grown in Greece alone is around 5,000 to 6,000 hectares, meaning that there is a sizeable, commercial opportunity for Cedroz beyond its consolidated uses as a post-planting nematicide in horticultural crops.お知らせ • Aug 15Eden Research plc Announces Executive ChangesEden Research plc announced the appointment of Ilshad Moulan as the Company's new Head of Regulatory Affairs. Ilshad will bring his experience in the agrochemical sector to lead Eden Research's regulatory strategy and execution, helping to ensure the successful global registration of its innovative crop protection solutions. Ilshad has strong expertise in regulatory affairs management having led teams and managed complex projects across the industry. With a BSc degree in Biochemistry and Cell Biology and an MSc degree in Crop Protection and Regulatory Science, his strong scientific background complements his regulatory expertise. At Dr. Knoell Consult Ltd, Ilshad led a team of nine, focusing on regulatory affairs. His career began at Agrauxine, where he played a key role in developing dossiers for biopesticide active ingredients and formulated plant protection products. Additionally, his previous roles at Evergreen Garden Care and Battelle involved supporting and managing regulatory submissions for conventional active ingredients and formulated products. Ilshad will be based at Eden Research's headquarters in Oxfordshire and will begin his new role immediately. He succeeds Dr. Mike Carroll who will retire at the end of a handover period. Mike has served as Eden's first-ever regulatory leader and played a key role in not only establishing Eden's in-house regulatory capabilities, but in successfully expanding the regulatory authorisations for Eden's existing and new products.お知らせ • Aug 13Eden Research plc Announces Biofungicide Regulatory Authorisation in GermanyEden Research plc announced that it has been granted regulatory authorisation for use of its biofungicide Mevalone in Germany. Mevalone is authorised for professional use on grapevines and apples to control Botrytis on grapes and for the prevention of storage diseases on apples. Renowned for its world-class white wines, Germany is the fourth largest wine-producing country in Europe. The nation is home to 13 designated wine regions accounting for a total area of 103,000 hectares. Germany is particularly famous for Riesling, a grape variety that produces some of the world's finest white wines and the most widely planted grape variety in Germany. In accordance with the EU's Green Deal and Farm to Fork Strategy, which aims to halve the use of pesticides by 2030 and increase consumer demand for organic produce, there has been a growing market drive to adopt more sustainable farming practices in the Central Europe region to reduce reliance on harmful conventional fungicides. With this latest approval, Eden Research alongside its commercial partner in the region, Sumi Agro Europe, will look to take a notable portion of Germany's biopesticide market share by providing local farmers with a sustainable alternative that performs in much the same way as conventional pesticides.お知らせ • Jul 17Eden Research plc Announces Appointment of Daniel Mulas García as Global Product and Marketing LeadEden Research plc announced the appointment of Daniel Mulas García as the Company's new Global Product and Marketing Leader with immediate effect. Daniel has extensive experience in sustainable crop protection, most recently working as Product Manager, Biostimulants and Biocontrol for Sipcam Iberia, an important commercial partner of Eden, for close to ten years. During his time with Sipcam, Daniel was responsible for the launch and management of many innovative crop protection and nutrition products, including playing a critical role in the success of Eden's Araw® biofungicide across the region. A key aspect of his role at Sipcam was to understand future trends in agriculture and regulation in order to address the needs of farmers by staying in close contact with key customers, influencers and policy makers to secure the full potential of the products within the portfolio. Daniel holds a Master's degree in Agronomical Engineering and a PhD in Agronomy from the Universidad de León. He will play a significant role as part of Eden's commercial team to help ensure that Eden's current and future products are well-aligned with the needs of farmers in an ever-changing regulatory and commercial environment. Daniel will also help the team to maximise revenue growth through the pursuit of ongoing expansions of the Company's product portfolio.お知らせ • Jun 24Eden Research plc Announces Biofungicide Label Extension in SpainEden Research plc announced that its flagship biofungicide has received authorisation for use in new crops and fungal pathogens in Spain. Mevalone®, marketed as Araw® in Spain by Sipcam Iberia (Sipcam), Eden's commercial partner in Spain, Portugal and several other countries, will now be permitted for use against powdery mildew on 22 new crops, botrytis cinerea on 20 new crops, rust disease on 8 new crops, and sclerotinia on 4 new crops. These new horticultural crops include a wide range of species such as avocados, kiwis, mangos, cherries, chickpeas, green beans, asparagus, leeks, and artichokes. Araw has been a well-established solution to prevent botrytis in grapes since it was launched in Spain in 2016. Following the first label expansion in 2021, Araw has become the reference biofungicide in a wide range of horticultural crops and berries, including blueberry, tomato, cucumber and lettuce. Araw helps growers to meet the highest quality standards and a large percentage of this produce is exported to other EU countries, as well as the UK and other premium markets. This has led to a significant increase in the commercialised volumes of Araw sold in Spain in recent years. This newly expanded label makes Araw one of the most versatile and reliable solutions to prevent fungal diseases in many crops under organic and conventional agriculture. Thanks to this new authorisation, obtained through Sipcam's local regulatory team, all relevant horticultural crops in Spain can now be protected with Araw representing an excellent opportunity in several crops of growing importance, such as avocado, mango, and almond, which has become the third largest tree crop in Spain after olives and grapes. Spain boasts the largest cultivated area of almond trees in the world and ranks third in terms of overall production. Eden anticipates that this growth of the addressable market for Araw will contribute to revenue in 2025 and beyond. Further details of this expansion will be provided in due course as commercialisation commences.お知らせ • Jun 13Eden Research plc Appoints Humair Tariq as New Global Commercial LeadEden Research plc announced the appointment of Humair Tariq as the Company's new Global Commercial Lead. Humair assumes his new role with immediate effect. Humair has considerable experience in the crop protection industry, most recently working for Syngenta as Portfolio Manager for biologicals, seed treatment and insect control. Prior to that, he held a series of global and regional positions with Syngenta in both Basel and Pakistan. Humair holds an MBA degree with a focus on marketing.お知らせ • May 09+ 1 more updateEden Research plc to Report Fiscal Year 2023 Results on May 07, 2024Eden Research plc announced that they will report fiscal year 2023 results on May 07, 2024お知らせ • May 08Eden Research plc Announces Appointment of Derek Mcallan as Non-Executive Director and as Chairman of the Audit Committee Following the Company's 2024 AGMEden Research plc announced the appointment of Derek McAllan as a Non-Executive Director of the Company with immediate effect. Derek is currently a Partner of RSM UK, a leading provider of audit, tax and consulting services in the UK, where he is responsible for business development and client service across a portfolio of companies. Prior to his move to RSM UK in 2020, Derek acted as a Partner at KPMG for seventeen years during which he had a significant number of life science clients including some with which he worked from their inception to ultimate exit (including listings on NASDAQ and AIM, and also trade sales). Derek's portfolio of audit clients also included a number of AIM-listed companies. Derek will act as Chairman of the Audit Committee following the Company's 2024 Annual General Meeting (the "AGM"). The current Chairman of the Audit Committee, Robin Cridland, will remain a Non-Executive Director following the AGM to ensure an orderly handover to Derek.お知らせ • Jan 31Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive DirectorEden Research plc announced that Richard Horsman has stepped down as non-executive director with immediate effect.お知らせ • Jan 22Eden Research plc Provides Revenue Guidance for the Full Year of 2023Eden Research plc provided revenue guidance for the full year of 2023. For full year, revenue is expected to have increased by approximately 72% to £3.1 million, £0.3 million, or 11%, ahead of market expectations of £2.8 million(Fiscal Year 2022: £1.8 million).お知らせ • Sep 30Eden Research plc to Report First Half, 2023 Results on Sep 29, 2023Eden Research plc announced that they will report first half, 2023 results on Sep 29, 2023お知らせ • Jul 04Eden Research plc Announces Regulatory Application for Authorised Use of Ecovelex™ in the United KingdomEden Research plc announced that it has applied for the authorisation of Ecovelex™ in its home country, the United Kingdom, following the recent application for authorisation in the European Union. Developed by Corteva Agriscience and Eden over the past three years, Ecovelex represents a new entrant into the seed treatment market and is intended to replace conventional chemicals banned in the EU and UK. It has been developed to tackle crop destruction caused by birds, a major cause of losses in maize and other crops. Ecovelex works by affecting the bird's olfactory system, creating an unpleasant taste or odour that repels the birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry and formulated using the Company's Sustaine® microencapsulation system, supporting farmers as they strive to meet consumer and regulator demands for more sustainable agriculture.お知らせ • Jun 09Eden Research plc, Annual General Meeting, Jun 29, 2023Eden Research plc, Annual General Meeting, Jun 29, 2023, at 10:00 Coordinated Universal Time. Location: 6-8 Tokenhouse Yard, EC2R 7AS London United Kingdom Agenda: To consider the annual report 2022; to confirm the appointment of PKF Littlejohn LLP as the Company's auditors to hold office until the conclusion of the next annual general meeting and to grant authority to the Directors to determine the auditors' remuneration; to elect as a Director, Richard Horsman, who, being eligible, is offering himself for election; to re-elect as a Director, Robin Cridland, who is voluntarily retiring and who, being eligible, is offering himself for re-election; and to discuss other matters.お知らせ • May 05Eden Research plc to Report Fiscal Year 2022 Results on May 05, 2023Eden Research plc announced that they will report fiscal year 2022 results on May 05, 2023お知らせ • Jan 31Eden Research plc Announces First Mevalone Authorisation for Domestic UseEden Research plc announced that its biofungicide, Mevalone, has received authorisation for home garden use in Italy for the control of a number of important plant pathogens affecting the home grower. The diseases include Botrytis cinerea and powdery mildew, destructive fungal pathogens affecting many plant species. Mevalone, which is marketed as 3LOGY in Italy, is already approved for agricultural use across a wide range of crops including: wine and table grapes, tomatoes, apple, pears, strawberries, cucumber, and many more. Approval for 3LOGY has now been granted for domestic use across a number of crops, allowing retailers to sell 3LOGY to gardeners in Italy for home applications. The use of 3LOGY affords farmers and home growers maximum flexibility in their plant and crop protection as it is free from residues and provides them the important benefit of avoiding higher-than-permitted pesticide residue levels as stipulated by the regulatory authorities. 3LOGY is distributed exclusively in Italy by Eden's distribution partner, Sipcam-Oxon (Sipcam). Based on natural active ingredients, 3LOGY is a useful tool in plant protection programmes and is aligned with the demanding requirements of integrated pest management programmes. Sipcam has extensive experience with 3LOGY and has also supported significant label extensions in Spain and Portugal. This approval will enable Sipcam to expand the market for 3LOGY into homes across Italy.お知らせ • Jan 10Eden Research plc Provides Revenue Guidance for the Full Year of 2022Eden Research plc provided revenue guidance for the full year of 2022. For full year, revenue is expected to have increased by approximately 50% to £1.8 million, £0.1 million, or 6%, ahead of market expectations of £1.7 million (Fiscal Year 2021: £1.2 million).収支内訳Eden Research の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:EDNS.F 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費30 Jun 244-24031 Mar 244-43031 Dec 233-63030 Sep 233-73030 Jun 232-73031 Mar 232-53031 Dec 222-23030 Sep 222-23030 Jun 221-23031 Mar 221-23031 Dec 211-33030 Sep 211-33030 Jun 212-33031 Mar 211-33031 Dec 201-22030 Sep 202-22030 Jun 202-23031 Mar 202-12031 Dec 192-12030 Sep 192-12030 Jun 19302031 Mar 19302031 Dec 18302030 Sep 182-12030 Jun 182-21031 Mar 182-11031 Dec 172-11030 Sep 172-12030 Jun 171-12031 Mar 171-12031 Dec 160-22030 Sep 161-21030 Jun 161-11031 Mar 161-11031 Dec 151-11030 Sep 151-21030 Jun 150-21031 Mar 150-31031 Dec 140-31030 Sep 140-31030 Jun 140-210質の高い収益: EDNS.Fは現在利益が出ていません。利益率の向上: EDNS.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: EDNS.Fは利益が出ておらず、過去 5 年間で損失は年間31.4%の割合で増加しています。成長の加速: EDNS.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: EDNS.Fは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( 2.1% ) と比較することは困難です。株主資本利益率高いROE: EDNS.Fは現在利益が出ていないため、自己資本利益率 ( -12.03% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/05/04 07:14終値2025/02/04 00:00収益2024/06/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Eden Research plc 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Andrew Murray DarleyCavendishAdam McCarterCavendishChristopher DonnellanCavendish2 その他のアナリストを表示
お知らせ • Sep 15Eden Research plc to Report First Half, 2025 Results on Sep 17, 2025Eden Research plc announced that they will report first half, 2025 results on Sep 17, 2025
お知らせ • Sep 20Eden Research plc to Report First Half, 2024 Results on Sep 23, 2024Eden Research plc announced that they will report first half, 2024 results on Sep 23, 2024
お知らせ • May 09+ 1 more updateEden Research plc to Report Fiscal Year 2023 Results on May 07, 2024Eden Research plc announced that they will report fiscal year 2023 results on May 07, 2024
お知らせ • Sep 30Eden Research plc to Report First Half, 2023 Results on Sep 29, 2023Eden Research plc announced that they will report first half, 2023 results on Sep 29, 2023
お知らせ • May 05Eden Research plc to Report Fiscal Year 2022 Results on May 05, 2023Eden Research plc announced that they will report fiscal year 2022 results on May 05, 2023
お知らせ • Apr 30Eden Research plc Provides Revenue Guidance for the Fifteen Months Ending 31 March 2026Eden Research plc provided revenue guidance for the fifteen months ending 31 March 2026. For the period, revenue is expected to be c. £4.9 million.
お知らせ • Feb 06Eden Research plc has completed a Follow-on Equity Offering in the amount of £0.150419 million.Eden Research plc has completed a Follow-on Equity Offering in the amount of £0.150419 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,760,473 Price\Range: £0.04
お知らせ • Feb 02+ 1 more updateEden Research plc has filed a Follow-on Equity Offering in the amount of £0.5 million.Eden Research plc has filed a Follow-on Equity Offering in the amount of £0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 12,500,000 Price\Range: £0.04
お知らせ • Jan 07Eden Research plc Announces Mevalone Label Extension in FranceEden Research plc announced that Mevalone has been granted approval by the French authorities for use on grapes to control downy and powdery mildew, subject to customary restrictions. France is one of the world's largest and most affected markets for grape downy mildew, and this is driving steady demand for conventional fungicides, biopesticides, and resistant varieties across its more- than 780,000 hectares of vines. While any estimate is subject to ever-evolving regulatory and commercial circumstances, the Company currently estimates that the potential peak revenue for this opportunity (with its current label extension conditions on the timing of applications) to be in the region of up to EUR8 million per annum. Given the timing of receipt of this label extension for two new diseases and the industry's schedule for marketing and stocking products for the growing season, the Company is not changing its market guidance at this stage but will monitor this as the season develops.
お知らせ • Nov 22Eden Research plc Announces 3Logy Receives Approval by the Italian Authorities for Use on Several New CropesEden Research plc announced that 3LOGY (predominantly known as Mevalone®? outside of Italy) has been granted approval by the Italian authorities for use on numerous new crops in order to control Botrytis and a range of new diseases, including powdery mildew and Sclerotinia. The label for 3LOGY has been expanded over time from a specialised fungicide for grey mould (Botrytis cinerea) in grapes to a broad-spectrum fungicide for multiple horticultural crops following its first label extension in Italy in 2022. Now a leading biofungicide in the Italian market, 3LOGY has efficacy on crops that require the highest quality standards, including leafy vegetables, table grapes, and kiwis. The new crops approved for 3LOGY include legumes (such as peas, lentils, and chickpeas) as well as other crops such as avocado, carrot, radish, celery and asparagus. Together, the new label extensions grow the addressable market in Italy by more than twenty thousand hectares and provide 3LOGY with the opportunity to play a key role in the sustainable cultivation of these high-value crops. Beyond the enlarged addressable market in Italy, 3LOGY offers additional value for growers simply due to the extensive list of crops on which it can now be used. This versatility allows farmers to use it as a reference fungicide across cultivated open fields and in greenhouses for certain crops. This label extension reflects Eden's ongoing strategy to grow its core business through the addition of not only new products, but also through the expansion of regulatory authorisations for existing products that have substantial additional potential beyond simple territorial expansions. This label extension enhances Eden's competitive position within the fungicide segment. Sipcam Italia and 3LOGY are now considered top-of-mind products for Italian growers in a market with limited options. Although the potential sales gains are difficult to quantify.
お知らせ • Nov 18Eden Research plc Announces Ecovelex 2025 Approval in ItalyEden Research plc announced that Ecovelextm 2025 has been granted temporary approval in Italy (in accordance with Reg. EU/1107/2009) for use as a bird repellent seed treatment on maize for the 2026 growing season. The temporary approval in Italy enables Eden to sell Ecovelex whilst await full EU-wide authorisation, which is expected in due course. Ecovelex represents a new entrant into the seed treatment market and is a replacement for conventional chemicals that are no longer approved in the EU and UK. It was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by emitting an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product, developed by Eden at its Oxfordshire facility, is based on Eden's plant-derived active ingredients, which the Company has registered in the EU, US, Mexico and elsewhere. Ecovelex has also been formulated using Eden's Sustaine®? plastic-free microencapsulation system. It is designed to support farmers as they strive to meet consumer and regulatory demands for more sustainable agriculture. In 2023, Eden submitted the regulatory dossier and application to Austria, which is acting as the interzonal rapporteur member state on behalf of the EU. Authorisation is expected in due course, with each EU member state then required to ratify the authorisation or request additional information before granting local authorisations.
お知らせ • Sep 15Eden Research plc to Report First Half, 2025 Results on Sep 17, 2025Eden Research plc announced that they will report first half, 2025 results on Sep 17, 2025
お知らせ • May 29Eden Research plc, Annual General Meeting, Jun 18, 2025Eden Research plc, Annual General Meeting, Jun 18, 2025. Location: one bartholomew close, ec1a 7bl, london United Kingdom
お知らせ • Dec 20Eden Research plc Receives Regulatory Approval in Mexico for Novellus+ in MexicoEden Research plc announced that it has received regulatory approval in Mexico for Novellus®?+, a new, enhanced version of its fungicide, Mevalone O. The product's regulatory approval applies to its use against botrytis on a range of horticultural crops, comprising grapes, tomatoes, peppers, potatoes, strawberries, blueberries, raspberries, Gooseberries, eggplant, okra, as well as several other high value fruit and vegetables. Novellus+ will be exclusively distributed and sold by Sipcam Oxon's Mexican subsidiary, Advan Mexico SA de CV ("Advan"). This is also an exciting development as Novellus+ represents an evolution of Mevalone, allowing improved rates in the field, high levels of efficacy and a broader list of targets, all contributing to a larger addressable market in select territories. Registration efforts are also well underway in several additional countries, and the company look forward to providing further updates on the growth of Novellus+ within portfolio. The company believe that the sustainability and efficacy of Novellus+ will stand company product apart in a growing market, particularly as local regulations increasingly demand strict control of pesticide residues on fruit and vegetables in order to meet consumer expectations and international standards. This milestone further strengthens the product development pipeline in key markets where Sipcam Oxon operates through its affiliates. With its high-value crops and vegetables, primarily grown for export, Mexico offers significant market potential for botanical products like Novellus+. The successful development of Novellus+ highlights the fruitful collaboration between Eden and Sipcam, combining their expertise to create an enhanced formulation that delivers consistent efficacy and versatility.
お知らせ • Dec 13Eden Research plc Announces That Its Fungicide, Mevalone Has Been Registered as an input for Organic Farming in GermanyEden Research plc announced that its fungicide, Mevalone, has been registered as an input for organic farming in Germany. The Input List for organic production in Germany is managed by the Research Institute of Organic Agriculture, FiBL, a European organisation with presence in several countries and with well-recognised and respected activities related to sustainability and organic farming. This inclusion has been granted by experts who evaluate farming inputs for their compliance with the requirements of organic production in Germany and multiple other countries. The news follows the approval of Mevalone in Germany, announced in August 2024. Eden's German commercial partner, Sumi Agro Deutschland, which has a strong focus on supporting organic farmers, has reinforced the importance of having this registration by FiBL Germany to better address the needs of organic growers in Germany. This policy exceeds the 25% of organic farmland in the EU as set in the EU Green Deal and means that significant action is required by the entire agriculture sector to reach this goal. Therefore, the registration of Mevalone as an input fororganic farming in Germany positions the product as a significant contributor to support German farmers to achieve their targets whilst also retaining productivity. With FiBL Germany's addition of Mevalone to the Organic Input list, Eden expects its fungicide to become an even more versatile product used by German organic growers to effectively control fungal diseases and to avoid production loss, whilst also remaining consistent with the requirements of organic agriculture.
お知らせ • Oct 08Eden Research Delists from the OTCQB Exchange in the USEden Research plc announced that it has, as of October 8, 2024, delisted from the OTCQB exchange in the US. Following a review of its capital markets strategy, the Board of Eden has taken the decision to delist the Company from the US-based OTCQB exchange in light of the low trading activity of the Company's ordinary shares on that exchange. The delisting will have no impact on the Company's ordinary shares, which will continue to trade on AIM.
お知らせ • Sep 20Eden Research plc to Report First Half, 2024 Results on Sep 23, 2024Eden Research plc announced that they will report first half, 2024 results on Sep 23, 2024
お知らせ • Sep 02Eden Research plc Announces Temporary Approval for Cedroz in GreeceEden Research plc announced that Cedroz has been granted, according to Reg. EU/1107/2009, a temporary approval in Greece for use on potatoes against wireworms for the 2024 growing season. Cedroz, whose distributor in Greece is Eastman Chemical; Eden's commercial partner in a number of countries, will now be permitted for use on potatoes against wireworms. Wireworms are the larvae of click beetles which cause damage to potatoes by forming a mass of holes and mini-tunnels on the vegetables. This pest is becoming increasingly problematic in many crops and regions, and farmers have very few options (most of them based on synthetic insecticides) to minimise its negative impact on the harvest. The Wireworm-infected area of potatoes grown in Greece alone is around 5,000 to 6,000 hectares, meaning that there is a sizeable, commercial opportunity for Cedroz beyond its consolidated uses as a post-planting nematicide in horticultural crops.
お知らせ • Aug 15Eden Research plc Announces Executive ChangesEden Research plc announced the appointment of Ilshad Moulan as the Company's new Head of Regulatory Affairs. Ilshad will bring his experience in the agrochemical sector to lead Eden Research's regulatory strategy and execution, helping to ensure the successful global registration of its innovative crop protection solutions. Ilshad has strong expertise in regulatory affairs management having led teams and managed complex projects across the industry. With a BSc degree in Biochemistry and Cell Biology and an MSc degree in Crop Protection and Regulatory Science, his strong scientific background complements his regulatory expertise. At Dr. Knoell Consult Ltd, Ilshad led a team of nine, focusing on regulatory affairs. His career began at Agrauxine, where he played a key role in developing dossiers for biopesticide active ingredients and formulated plant protection products. Additionally, his previous roles at Evergreen Garden Care and Battelle involved supporting and managing regulatory submissions for conventional active ingredients and formulated products. Ilshad will be based at Eden Research's headquarters in Oxfordshire and will begin his new role immediately. He succeeds Dr. Mike Carroll who will retire at the end of a handover period. Mike has served as Eden's first-ever regulatory leader and played a key role in not only establishing Eden's in-house regulatory capabilities, but in successfully expanding the regulatory authorisations for Eden's existing and new products.
お知らせ • Aug 13Eden Research plc Announces Biofungicide Regulatory Authorisation in GermanyEden Research plc announced that it has been granted regulatory authorisation for use of its biofungicide Mevalone in Germany. Mevalone is authorised for professional use on grapevines and apples to control Botrytis on grapes and for the prevention of storage diseases on apples. Renowned for its world-class white wines, Germany is the fourth largest wine-producing country in Europe. The nation is home to 13 designated wine regions accounting for a total area of 103,000 hectares. Germany is particularly famous for Riesling, a grape variety that produces some of the world's finest white wines and the most widely planted grape variety in Germany. In accordance with the EU's Green Deal and Farm to Fork Strategy, which aims to halve the use of pesticides by 2030 and increase consumer demand for organic produce, there has been a growing market drive to adopt more sustainable farming practices in the Central Europe region to reduce reliance on harmful conventional fungicides. With this latest approval, Eden Research alongside its commercial partner in the region, Sumi Agro Europe, will look to take a notable portion of Germany's biopesticide market share by providing local farmers with a sustainable alternative that performs in much the same way as conventional pesticides.
お知らせ • Jul 17Eden Research plc Announces Appointment of Daniel Mulas García as Global Product and Marketing LeadEden Research plc announced the appointment of Daniel Mulas García as the Company's new Global Product and Marketing Leader with immediate effect. Daniel has extensive experience in sustainable crop protection, most recently working as Product Manager, Biostimulants and Biocontrol for Sipcam Iberia, an important commercial partner of Eden, for close to ten years. During his time with Sipcam, Daniel was responsible for the launch and management of many innovative crop protection and nutrition products, including playing a critical role in the success of Eden's Araw® biofungicide across the region. A key aspect of his role at Sipcam was to understand future trends in agriculture and regulation in order to address the needs of farmers by staying in close contact with key customers, influencers and policy makers to secure the full potential of the products within the portfolio. Daniel holds a Master's degree in Agronomical Engineering and a PhD in Agronomy from the Universidad de León. He will play a significant role as part of Eden's commercial team to help ensure that Eden's current and future products are well-aligned with the needs of farmers in an ever-changing regulatory and commercial environment. Daniel will also help the team to maximise revenue growth through the pursuit of ongoing expansions of the Company's product portfolio.
お知らせ • Jun 24Eden Research plc Announces Biofungicide Label Extension in SpainEden Research plc announced that its flagship biofungicide has received authorisation for use in new crops and fungal pathogens in Spain. Mevalone®, marketed as Araw® in Spain by Sipcam Iberia (Sipcam), Eden's commercial partner in Spain, Portugal and several other countries, will now be permitted for use against powdery mildew on 22 new crops, botrytis cinerea on 20 new crops, rust disease on 8 new crops, and sclerotinia on 4 new crops. These new horticultural crops include a wide range of species such as avocados, kiwis, mangos, cherries, chickpeas, green beans, asparagus, leeks, and artichokes. Araw has been a well-established solution to prevent botrytis in grapes since it was launched in Spain in 2016. Following the first label expansion in 2021, Araw has become the reference biofungicide in a wide range of horticultural crops and berries, including blueberry, tomato, cucumber and lettuce. Araw helps growers to meet the highest quality standards and a large percentage of this produce is exported to other EU countries, as well as the UK and other premium markets. This has led to a significant increase in the commercialised volumes of Araw sold in Spain in recent years. This newly expanded label makes Araw one of the most versatile and reliable solutions to prevent fungal diseases in many crops under organic and conventional agriculture. Thanks to this new authorisation, obtained through Sipcam's local regulatory team, all relevant horticultural crops in Spain can now be protected with Araw representing an excellent opportunity in several crops of growing importance, such as avocado, mango, and almond, which has become the third largest tree crop in Spain after olives and grapes. Spain boasts the largest cultivated area of almond trees in the world and ranks third in terms of overall production. Eden anticipates that this growth of the addressable market for Araw will contribute to revenue in 2025 and beyond. Further details of this expansion will be provided in due course as commercialisation commences.
お知らせ • Jun 13Eden Research plc Appoints Humair Tariq as New Global Commercial LeadEden Research plc announced the appointment of Humair Tariq as the Company's new Global Commercial Lead. Humair assumes his new role with immediate effect. Humair has considerable experience in the crop protection industry, most recently working for Syngenta as Portfolio Manager for biologicals, seed treatment and insect control. Prior to that, he held a series of global and regional positions with Syngenta in both Basel and Pakistan. Humair holds an MBA degree with a focus on marketing.
お知らせ • May 09+ 1 more updateEden Research plc to Report Fiscal Year 2023 Results on May 07, 2024Eden Research plc announced that they will report fiscal year 2023 results on May 07, 2024
お知らせ • May 08Eden Research plc Announces Appointment of Derek Mcallan as Non-Executive Director and as Chairman of the Audit Committee Following the Company's 2024 AGMEden Research plc announced the appointment of Derek McAllan as a Non-Executive Director of the Company with immediate effect. Derek is currently a Partner of RSM UK, a leading provider of audit, tax and consulting services in the UK, where he is responsible for business development and client service across a portfolio of companies. Prior to his move to RSM UK in 2020, Derek acted as a Partner at KPMG for seventeen years during which he had a significant number of life science clients including some with which he worked from their inception to ultimate exit (including listings on NASDAQ and AIM, and also trade sales). Derek's portfolio of audit clients also included a number of AIM-listed companies. Derek will act as Chairman of the Audit Committee following the Company's 2024 Annual General Meeting (the "AGM"). The current Chairman of the Audit Committee, Robin Cridland, will remain a Non-Executive Director following the AGM to ensure an orderly handover to Derek.
お知らせ • Jan 31Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive DirectorEden Research plc announced that Richard Horsman has stepped down as non-executive director with immediate effect.
お知らせ • Jan 22Eden Research plc Provides Revenue Guidance for the Full Year of 2023Eden Research plc provided revenue guidance for the full year of 2023. For full year, revenue is expected to have increased by approximately 72% to £3.1 million, £0.3 million, or 11%, ahead of market expectations of £2.8 million(Fiscal Year 2022: £1.8 million).
お知らせ • Sep 30Eden Research plc to Report First Half, 2023 Results on Sep 29, 2023Eden Research plc announced that they will report first half, 2023 results on Sep 29, 2023
お知らせ • Jul 04Eden Research plc Announces Regulatory Application for Authorised Use of Ecovelex™ in the United KingdomEden Research plc announced that it has applied for the authorisation of Ecovelex™ in its home country, the United Kingdom, following the recent application for authorisation in the European Union. Developed by Corteva Agriscience and Eden over the past three years, Ecovelex represents a new entrant into the seed treatment market and is intended to replace conventional chemicals banned in the EU and UK. It has been developed to tackle crop destruction caused by birds, a major cause of losses in maize and other crops. Ecovelex works by affecting the bird's olfactory system, creating an unpleasant taste or odour that repels the birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry and formulated using the Company's Sustaine® microencapsulation system, supporting farmers as they strive to meet consumer and regulator demands for more sustainable agriculture.
お知らせ • Jun 09Eden Research plc, Annual General Meeting, Jun 29, 2023Eden Research plc, Annual General Meeting, Jun 29, 2023, at 10:00 Coordinated Universal Time. Location: 6-8 Tokenhouse Yard, EC2R 7AS London United Kingdom Agenda: To consider the annual report 2022; to confirm the appointment of PKF Littlejohn LLP as the Company's auditors to hold office until the conclusion of the next annual general meeting and to grant authority to the Directors to determine the auditors' remuneration; to elect as a Director, Richard Horsman, who, being eligible, is offering himself for election; to re-elect as a Director, Robin Cridland, who is voluntarily retiring and who, being eligible, is offering himself for re-election; and to discuss other matters.
お知らせ • May 05Eden Research plc to Report Fiscal Year 2022 Results on May 05, 2023Eden Research plc announced that they will report fiscal year 2022 results on May 05, 2023
お知らせ • Jan 31Eden Research plc Announces First Mevalone Authorisation for Domestic UseEden Research plc announced that its biofungicide, Mevalone, has received authorisation for home garden use in Italy for the control of a number of important plant pathogens affecting the home grower. The diseases include Botrytis cinerea and powdery mildew, destructive fungal pathogens affecting many plant species. Mevalone, which is marketed as 3LOGY in Italy, is already approved for agricultural use across a wide range of crops including: wine and table grapes, tomatoes, apple, pears, strawberries, cucumber, and many more. Approval for 3LOGY has now been granted for domestic use across a number of crops, allowing retailers to sell 3LOGY to gardeners in Italy for home applications. The use of 3LOGY affords farmers and home growers maximum flexibility in their plant and crop protection as it is free from residues and provides them the important benefit of avoiding higher-than-permitted pesticide residue levels as stipulated by the regulatory authorities. 3LOGY is distributed exclusively in Italy by Eden's distribution partner, Sipcam-Oxon (Sipcam). Based on natural active ingredients, 3LOGY is a useful tool in plant protection programmes and is aligned with the demanding requirements of integrated pest management programmes. Sipcam has extensive experience with 3LOGY and has also supported significant label extensions in Spain and Portugal. This approval will enable Sipcam to expand the market for 3LOGY into homes across Italy.
お知らせ • Jan 10Eden Research plc Provides Revenue Guidance for the Full Year of 2022Eden Research plc provided revenue guidance for the full year of 2022. For full year, revenue is expected to have increased by approximately 50% to £1.8 million, £0.1 million, or 6%, ahead of market expectations of £1.7 million (Fiscal Year 2021: £1.2 million).